Daratumumab combination treatment approved for use on the NHS in Scotland
Myeloma patients at first relapse in Scotland will now be able to access the new treatment of daratumumab (Darzalex®), bortezomib (Velcade®) and dexamethasone on the NHS after it was approved for use by the Scottish Medicines Consortium (SMC). This decision brings Scotland into line with the rest of the UK following the decision by NICE…
Details